12 Results for "

LNP formulation

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "LNP formulation" in MCE Product Catalog:

Cat. No.: HY-143692
CAS No.: 123036-44-2
Purity:  ≥99.0%
SQDG inhibits topoisomerase I and P-selectin receptor, exhibits anti-inflammatory, antiviral and antitumor activities. SQDG is a glycolipid that possesses sugar moieties in their head groups. SQDG is a membrane lipid that can be used to investigate the effects of structural lipid in LNP formulations .
loading...
    loading...
Cat. No.: HY-153235
Target:  

mRNA SARS-CoV Liposome

Research Areas:  

Infection

COVID-19 Spike Protein mRNA-LNP is a lipid nanoparticle (LNP) containing mRNA encoding COVID-19 Spike Protein. COVID-19 Spike Protein undertakes the functions of virus binding with host cell receptors, thereby mediating the entry of COVID-19 virus into cells. COVID-19 Spike Protein is an important site of action for host neutralizing antibodies and a key target for vaccine design. COVID-19 Spike Protein mRNA-LNP can be used for RNA delivery, vaccine formulation and design targeting SARS-CoV-2 .
loading...
    loading...
Cat. No.: HY-137499
CAS No.: 2739805-63-9
Purity:  ≥95.0%
Research Areas:  

Neurological Disease

NT1-O12B, an endogenous chemical and a neurotransmitter-derived lipidoid (NT-lipidoid), is an effective carrier for enhanced brain delivery of several blood-brain barrier (BBB)-impermeable cargos. Doping NT1-O12B into BBB-impermeable lipid nanoparticles (LNPs) gives the LNPs the ability to cross the BBB. NT-lipidoids formulation not only facilitate cargo crossing of the BBB, but also delivery of the cargo into neuronal cells for functional gene silencing or gene recombination .
loading...
    loading...
Cat. No.: HY-156100
CAS No.: 2639634-71-0
Target:  

Liposome

Research Areas:  

Others

C12-4 is an ionizable lipid for lipid nanoparticles (LNPs) formulation.
loading...
    loading...
Cat. No.: HY-171898
CAS No.: 3046404-81-0
Target:  

Liposome

Research Areas:  

Inflammation/Immunology Cancer

Lipid I97 is an ionizable lipid derived from vitamin B5 (pKa = 6.23). Lipid I97 can be used to generate lipid nanoparticles (LNPs) for mRNA delivery in vivo. Lipid I97 can be studied in research for enhancing mRNA transfection efficiency and long-term stability as well as formulation of mRNA vaccines .
loading...
    loading...
Cat. No.: HY-165604
CAS No.: 2639634-82-3
Target:  

Liposome

Research Areas:  

Others

C14-490 is an ionizable cationic lipid used for the formulation of lipid nanoparticles (LNPs) for mRNA delivery. C14-490 LNPs can be surface-functionalized with CD45 antibodies to enable targeted delivery to hematopoietic stem cells (HSCs), mediate efficient mRNA delivery and CRISPR-Cas9 gene editing in fetal HSCs in utero, with potent and durable genome modulation in HSCs and their progeny. C14-490 is a key component of the Systematically optimized Targeted Editing Machinery (STEM) LNPs for in vivo HSC gene editing applications .
loading...
    loading...
Cat. No.: HY-185977
CAS No.: 3113145-01-7
Target:  

Liposome

Research Areas:  

Others

a12Dab4 is a peptide ionizable lipid (PIL) used in lipid nanoparticle (LNP) formulations for targeted delivery of mRNA to the liver .
loading...
    loading...
Cat. No.: HY-185284
Target:  

Liposome

Research Areas:  

Others

MeDZ lipid is a zwitterion-type ionizable endosomal membrane destabilizer and anti-inflammatory agent that promotes endosomal escape. When incorporated into LNP formulations, MeDZ lipid enhances mRNA expression in lymph node antigen-presenting cells and promotes cytotoxic T cell activation. MeDZ lipid is compatible with existing targeted nanoparticle formulations to improve mRNA delivery efficiency .
loading...
    loading...
Cat. No.: HY-W1130407
CAS No.: 3112948-09-8
Synonyms: VC-LC-1073
Target:  

Liposome

Research Areas:  

Others

CP-LC-1073 is a specific ionizable cationic amino lipid derived from the amino acid homocysteine. CP-LC-1073 can used in lipid nanoparticle (LNP) formulations for efficient in vivo delivery and expression of RNA (mRNA, cRNA, saRNA).
loading...
    loading...
Cat. No.: HY-185760
Target:  

Liposome

Research Areas:  

Others

F-L319 is an ionizable lipid and spleen-targeting mRNA delivery vector. F-L319 can be formulated into lipid nanoparticles (LNPs) to drive spleen-restricted reporter protein expression in mice. F-L319 modulates mRNA encapsulation efficiency, cellular uptake efficiency, and delivery efficiency, with effects varying depending on the composition of LNP formulations. When prepared as pure LNPs, F-L319 shows poor mRNA delivery efficiency in cells; in contrast, hybrid LNPs containing F-L319 and L319 significantly enhance mRNA delivery efficiency in cells .
loading...
    loading...
Cat. No.: HY-176027
Target:  

Liposome

Research Areas:  

Others

CP-LC-1422 is a homocysteine-derived ionizable amino lipid with high RNA delivery capability and can mediate high-level protein expression in vivo. CP-LC-1422 exhibits significant spleen targeting via intravenous injection in a lipid nanoparticle (LNP) formulation with no significant toxicity observed .
loading...
    loading...
Cat. No.: HY-P12013
Research Areas:  

Inflammation/Immunology

PEG12KL4 is a PEG-modified amphipathic cell-penetrating peptide. PEG12KL4 promotes the transfection and delivery of mRNA into lung cells, maintains mRNA stability, and forms mRNA complexes that retain integrity and translatability. PEG12KL4 endows lipid nanoparticles (LNPs) with anti-nebulization properties, enhances transfection efficiency in artificial mucus when used in combination with LNPs, and enables the formation of dry powder formulations with low toxicity and mild inflammatory responses. PEG12KL4 can be used in studies related to drug delivery for pulmonary diseases (cystic fibrosis, chronic obstructive pulmonary disease) .
loading...
    loading...
  • 1